The $4.9M cash injection is a material liquidity event for a $7M market cap company, likely extending runway through key milestones. However, the new warrant overhang (1.07M shares at $6.25, well above current price) creates a ceiling on upside. Monitor the resale registration statement filing within 15 days and any subsequent share price reaction near the $6.25 strike. The 20-day lock-up limits further dilution near-term.
Price Chart
Executive Summary
Autonomix Medical entered into a warrant inducement agreement with a holder of Series D-1/D-2 warrants, resulting in the immediate exercise of 857,462 existing warrants at $5.75/share for ~$4.9M gross proceeds, and the issuance of new Series E-1/E-2 warrants for up to 1,071,826 shares at $6.25. The $4.9M cash infusion provides near-term runway for a micro-cap with a $7M market cap, but the issuance of new warrants creates significant future dilution overhang. The filing is net positive for liquidity but carries dilution risk.
Key Financial Metrics
Key Facts
- Holder exercised 857,462 existing Series D-1/D-2 warrants at $5.75/share, generating ~$4.9M gross proceeds.
- Company issued new Series E-1 and E-2 warrants to purchase up to 535,913 shares each (total 1,071,826 shares) at $6.25/share, exercisable for 5 years.
- New warrants are unregistered and issued under Section 4(a)(2) exemption; company must file resale registration statement within 15 days.
- Maxim Group LLC acted as financial advisor, receiving 7.0% cash fee on proceeds (~$343,000) plus up to $15,000 expense reimbursement.
- Company agreed to a 20-day lock-up on further equity issuances (through September 13, 2026), excluding exempt issuances.
Financial Impact
~$4.9M gross proceeds from warrant exercise, offset by ~$358K in fees to Maxim. New warrants add potential dilution of up to 1,071,826 shares at $6.25 strike.
Risk Factors
- New warrants create significant dilution overhang (1.07M shares, ~125% of exercised shares) that may cap stock appreciation.
- Resale registration statement must be filed within 15 days; any delay could trigger penalty provisions and negative sentiment.
- Micro-cap ($7M) with low institutional ownership (top holder at $25K) — stock is highly volatile and illiquid.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-029024 |
| Document: 0001437749-26-029024-index.html | 0001437749-26-029024 |
| Document: 0001437749-26-029024.txt | 0001437749-26-029024 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | 3 | $3.01 | awaiting T+20 | — | $2.35 (−21.90%) |
Oct 2, 2026 24d ago | Press Release | $3.78 | awaiting T+20 | — | $2.35 (−37.81%) |
Sep 16, 2026 5w ago | 8-K | $4.12 $3.01 | ▼ −26.94% | ▼ −30.12% | $2.35 (−42.94%) |
Sep 16, 2026 5w ago | EFFECT | $4.12 $3.01 | ▲ +26.94% | ▲ +30.12% | $2.35 (+42.94%) |
Sep 11, 2026 6w ago | 424B5 | $4.33 $3.10 | ▲ +28.41% | ▲ +30.67% | $2.35 (+45.71%) |
Sep 4, 2026 7w ago | S-3 | $4.58 $3.47 | ▲ +24.24% | ▲ +25.95% | $2.35 (+48.67%) |
Aug 26, 2026 8w ago | 8-K | $5.63 $4.07 | ▼ −27.71% | ▼ −27.20% | $2.35 (−58.24%) |
Aug 5, 2026 11w ago | EFFECT | $12.10 $4.50 | ▼ −62.81% | ▼ −62.21% | $2.35 (−80.57%) |
Jul 28, 2026 12w ago | 8-K | $2.75 $7.19 | ▲ +161.45% | ▲ +158.07% | $2.35 (−14.51%) |
Jul 15, 2026 14w ago | 8-K | $4.92 $6.86 | ▼ −39.43% | ▼ −35.81% | $2.35 (+52.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers